Skip to content
AboutFrameworkInitiativesRM3PeopleEventsResources
Collaborate

Justified confidence in medical product safety and effectiveness.

Medical Product Safety & Effectiveness Institute is a California nonprofit public benefit corporation and intends to seek recognition as a tax-exempt organization under Section 501(c)(3). MPSEI is a trademark of Medical Product Safety & Effectiveness Institute.

info@mpsei.org

Institute

  • About
  • Framework
  • People

Work

  • Initiatives
  • RM3
  • Events
  • Resources

Governance

  • RM3 antitrust statement
  • Collaborate
  • Contact

Medical Product Safety & Effectiveness Institute

PrivacyTermsAccessibility

Events

MPSEI events and programs focus on safety, effectiveness, risk management, and collaboration across the medical product ecosystem.

Structured knowledge-exchange forum: a presentation stage with a lectern and evidence panel faces two shallow audience arcs; one communication arc travels outward, one feedback arc returns to a single completion point at the stage.

First-Principles Risk Management for Medical Products Workshop

A workshop dedicated to the First-Principles Risk Management initiative. Date and location to be announced.

First-Principles Decision Excellence & Organizational Maturity Workshop

A workshop dedicated to the First-Principles Decision Excellence & Organizational Maturity initiative. Date and location to be announced.

First-Principles Safety & Effectiveness Engineering for Combination Products Workshop

A workshop dedicated to the First-Principles Safety & Effectiveness Engineering for Combination Products initiative. Date and location to be announced.

International MedTech Safety Conference (IMSC26)

An RM3 panel introduced the initiative's goals, structure, progress, guiding principles, maturity domains, and initial assessment concepts, with discussion focused on patient safety, sound product decision-making, regulatory alignment, and practical use of the model.

June 5, 2026
  • RM3 Group Photo with FDA Director Dr. Michelle Tarver
  • RM3 Panel Discussion with FDA
  • RM3 panelists standing together in front of the Risk Management Maturity Model presentation screens.
  • Fubin Wu, RM3 Chair presenting
  • The RM3 panel session in progress, with panelists seated before two presentation screens.
  • International MedTech Safety Conference (IMSC26) display

Participants serve in their individual professional capacities unless expressly stated otherwise. Employer affiliations are provided for identification only and do not imply organizational membership, representation, sponsorship, or endorsement.

More programs pending

Programs are announced as they are confirmed.